Wie stehen die aktuellen Quoten für FDA Approves Openwater Cancer Treatment by 2032?

Manifold Markets bewertet No mit 81.9% (Stand: 10. Oktober 2026).

Wann wird FDA Approves Openwater Cancer Treatment by 2032 entschieden?

FDA Approves Openwater Cancer Treatment by 2032 soll am 2. Januar 2032 entschieden werden.

Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriert

Aktuelle Community-Prognose

Nein 81.9%

Prognostiker

Fragetyp

binary

Methodik

Play-money forecasting platform

Quellentyp

Prognose

Marktdaten

Aktualisiert vor 2 Stunden

Veraltet

14. Jan. 25, 02:36 UTC2. Jan. 32, 07:59 UTC

Trends

Ergebnis24hWahrscheinlichkeit

Regeln

Openwater (https://openwater.health) has a device that damages cancer cells selectively with ultrasound.

This market will resolve YES if any cancer treatment using Openwater's ultrasound technology is approved by the FDA before January 1, 2032 for one or more cancer indications.
Any FDA approval for treating cancer outside of a clinical trial counts, even if it only covers a small set of patients.
If Openwater's technology gets transferred to another entity, use of that technology will count as long as it involves focused ultrasound.
I have a blog post about the treatment here: https://bayesianinvestor.com/blog/index.php/2025/01/13/openwaters-cancer-treatment/